Free Trial

TradeUP Acquisition (UPTDW) Competitors

$0.04 +0.00 (+1.09%)
As of 08/8/2025

UPTDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

TradeUP Acquisition vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and TradeUP Acquisition (NASDAQ:UPTDW) are both pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
TradeUP AcquisitionN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled TradeUP Acquisition'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
TradeUP Acquisition Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
TradeUP Acquisition N/A N/A N/A

Summary

180 Life Sciences and TradeUP Acquisition tied by winning 0 of the 0 factors compared between the two stocks.

Get TradeUP Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPTDW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPTDW vs. The Competition

MetricTradeUP AcquisitionBiological Products, Except Diagnostic Substances IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$216.64M$2.54B$9.61B
Dividend YieldN/AN/A2.57%4.14%
P/E RatioN/AN/A22.2424.84
Price / SalesN/AN/A81.1398.72
Price / CashN/AN/A26.4958.36
Price / BookN/AN/A39.315.65
Net IncomeN/AN/A$28.61M$265.77M
7 Day PerformanceN/A-9.44%1.74%4.62%
1 Month PerformanceN/A-17.44%0.91%0.77%
1 Year PerformanceN/A152.44%28.89%22.14%

TradeUP Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPTDW
TradeUP Acquisition
N/A$0.04
+1.1%
N/AN/A$0.00N/A0.003
ATNFW
180 Life Sciences
N/A$0.01
-0.9%
N/A+22.0%$0.00N/A0.007Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%
N/A-75.5%$0.00N/A0.002
AIMDW
Ainos
N/A$0.11
-8.3%
N/A+314.3%$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.60
-17.5%
N/A-52.6%$0.00$585.60M0.004Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
+2.9%
N/A-35.8%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.15
-2.6%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.02
+19.3%
N/A-96.8%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.03
-12.0%
N/A-83.7%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:UPTDW) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners